Mary Ann Hanagan
DuPont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mary Ann Hanagan.
Bioorganic & Medicinal Chemistry | 2016
Robert James Pasteris; Mary Ann Hanagan; John Joseph Bisaha; Bruce L. Finkelstein; Lisa E. Hoffman; Vann Gregory; John L. Andreassi; James A. Sweigard; Boris A. Klyashchitsky; Yewande T. Henry; Richard A. Berger
Oxathiapiprolin is the first member of a new class of piperidinyl thiazole isoxazoline fungicides with exceptional activity against plant diseases caused by oomycete pathogens. It acts via inhibition of a novel fungal target-an oxysterol binding protein-resulting in excellent preventative, curative and residual efficacy against key diseases of grapes, potatoes and vegetables. Oxathiapiprolin is being developed globally as DuPont™ Zorvec™ disease control with first registration and sales anticipated in 2015. The discovery, synthesis, optimization and biological efficacy are presented.
Archive | 2007
Robert James Pasteris; Mary Ann Hanagan; Rafael Shapiro
Archive | 1987
Mary Ann Hanagan; Barry Arthur Wexler
Archive | 2010
Mary Ann Hanagan; Matthew Richard Oberholzer; Robert James Pasteris; Rafael Shapiro
Archive | 2009
Balreddy Kamireddy; Robert James Pasteris; Mary Ann Hanagan
Archive | 2011
Mary Ann Hanagan; Andris Juris Liepa; Eric Allen Marshall; Robert James Pasteris
Archive | 1992
Zen-Yu Chang; Mary Ann Hanagan; Thomas Paul Selby; Deborah Ann Frasier
Archive | 1983
Mary Ann Hanagan; Mark E. Thompson
Archive | 2009
Thomas Paul Selby; James Francis Bereznak; John Joseph Bisaha; Amy X. Ding; Vijayagopal Gopalsamuthiram; Mary Ann Hanagan; Jeffrey Keith Long; Andrew Edmund Taggi
Archive | 1984
Mary Ann Hanagan; James Volney Hay; Chi Ping Tseng